𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Heregulin protects mesenchymal stem cells from serum deprivation and hypoxia-induced apoptosis

✍ Scribed by Chun Gui; Jian An Wang; Ai Na He; Tie Long Chen; Rong Hua Luo; Jun Jiang; Xin Yang Hu; Xiao Jie Xie

Publisher
Springer
Year
2007
Tongue
English
Weight
337 KB
Volume
305
Category
Article
ISSN
0300-8177

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Lovastatin protects mesenchymal stem cel
Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2
✍ Ruixia Xu; Jinghai Chen; Xiangfeng Cong; Shengshou Hu; Xi Chen πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 674 KB

## Abstract Cell therapy with bone marrow‐derived mesenchymal stem cells (MSCs) has been shown to have great promises in cardiac repair after myocardial infarction. However, poor viability of transplanted MSCs in the infracted heart has limited the therapeutic efficacy. Our previous studies have sh

LPA rescues ER stress-associated apoptos
LPA rescues ER stress-associated apoptosis in hypoxia and serum deprivation-stimulated mesenchymal stem cells
✍ Zongwei Li; Hua Wei; Xuebin Liu; Shengshou Hu; Xiangfeng Cong; Xi Chen πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 395 KB

## Abstract Poor viability of transplanted mesenchymal stem cells (MSCs) in the infracted heart has limited their therapeutic efficacy in cardiac repair after myocardial infarction. We previously demonstrated that hypoxia and serum deprivation (hypoxia/SD) induced mitochondria‐dependent apoptosis i